# NORETHINDRONE
> **ANDA202260** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2013-08-01
## Drug
- **FDA Application Number:** ANDA202260
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NORETHINDRONE
- **Generic name:** Norethindrone
- **Active ingredients:** NORETHINDRONE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL PHARMS
- **First approval:** 2013-08-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202260)
---
*MORVS · CC0 1.0*